Randomised crossover study on pulse oximeter readings from different sensors in very preterm infants.
Autor: | Maiwald CA; Department of Pediatrics, Center for Pediatric Clinical Studies (CPCS), University Hospital Tübingen, Tübingen, Germany.; Department of Neonatology, Tübingen University Hospital, Tübingen, Germany., Schwarz CE; Department of Neonatology, Tübingen University Hospital, Tübingen, Germany.; Department of Neonatology, University of Heidelberg, Heidelberg, Germany., Böckmann K; Department of Neonatology, Tübingen University Hospital, Tübingen, Germany., Springer L; Department of Neonatology, Tübingen University Hospital, Tübingen, Germany., Poets CF; Department of Neonatology, Tübingen University Hospital, Tübingen, Germany christian-f.poets@med.uni-tuebingen.de., Franz A; Department of Pediatrics, Center for Pediatric Clinical Studies (CPCS), University Hospital Tübingen, Tübingen, Germany.; Department of Neonatology, Tübingen University Hospital, Tübingen, Germany. |
---|---|
Jazyk: | angličtina |
Zdroj: | Archives of disease in childhood. Fetal and neonatal edition [Arch Dis Child Fetal Neonatal Ed] 2024 Jun 19; Vol. 109 (4), pp. 391-396. Date of Electronic Publication: 2024 Jun 19. |
DOI: | 10.1136/archdischild-2023-325961 |
Abstrakt: | Objective: In extremely preterm infants, different target ranges for pulse oximeter saturation (SpO Design: Single-centre, randomised, triple crossover study. Setting: Tertiary neonatal intensive care unit. Patients: 24 infants, born at <32 weeks' gestation, with current weight <1500 g and without right-to-left shunt via a patent ductus arteriosus. Interventions: Simultaneous readings from three SpO Outcomes: Primary outcome was the difference in SpO Results: Mean gestational age at birth (±SD) was 27 4/7 (±2 3/7 ) weeks, postnatal age 20 (±20) days. 134 hours of recording were analysed. Mean SpO Conclusion: There were systematic differences in SpO Trial Registration Number: DRKS00027285. Competing Interests: Competing interests: CFP received advisory board-honoraria from Masimo, Irvine, California in 09/2020. All other authors have indicated they have no conflicts of interests relevant to this article to disclose. AF and CFP declare that Masimo generously supported SpO2 measurements in a previous and an ongoing clinical trial. In this study, Masimo provided also the required LNCS, RD and PPG sensors. However, Masimo had no impact on the design of this study, analysis of the data and writing of this manuscript. (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.) |
Databáze: | MEDLINE |
Externí odkaz: |